Skip to main content
. 2015 Dec 23;351:h6544. doi: 10.1136/bmj.h6544

Table 1.

Baseline characteristics of women with uncomplicated urinary tract infection randomised to ibuprofen or fosfomycin. Figures are numbers of women (percentage) unless stated otherwise

Ibuprofen (n=241) Fosfomycin (n=243)
Mean (SD) age (years) 37.3 (14.6) 37.3 (14.3)
Median (IQR) age (years) 36.0 (24.0-50.0) 34.0 (24.0-49.0)
Duration of symptoms at inclusion (days)*:
 <1 50 (21) 49 (21)
 1-2 104 (43) 80 (34)
 >2-7 66 (27) 82 (34)
 >7 21 (9) 28 (12)
Symptoms at inclusion*:
 Dysuria 224 (93) 218 (91)
 Frequency/urgency 231 (96) 232 (97)
 Low abdominal pain 172 (71) 169 (71)
Mean (SD) symptom severity sum score† 6.0 (2.2) 6.1 (2.5)
Median (IQR) symptom severity sum score† 6.0 (4.0-8.0) 6.0 (4.0-8.0)
Mean (SD) dysuria score‡ 2.3 (1.0) 2.3 (1.1)
Median (IQR) dysuria score‡ 3.0 (2.0-3.0) 2.0 (1.0-3.0)
Mean (SD) frequency/urgency score‡ 2.4 (1.1) 2.4 (1.1)
Median (IQR) frequency/urgency score‡ 2.0 (2.0-3.0) 2.0 (2.0-3.0)
Mean (SD) low abdominal pain score‡ 1.3 (1.1) 1.4 (1.1)
Median (IQR) low abdominal pain score‡ 1.0 (0.0-2.0) 1.0 (0.0-2.0)
Recurrent UTI§ 42 (17) 54 (23)
Mean (SD) activity impairment score¶ 9.6 (5) 8.9 (6)
Dipstick results**:
 Leukocytes positive 205 (85) 200 (83)
 Erythrocytes positive 180 (75) 189 (78)
 Nitrite positive 53 (22) 46 (19)
Culture results:
 Urine culture positive†† 179/237 (76) 181/234 (77)
E coli 143/179 (80) 142/181 (79)
Proteus mirabilis 12/179 (7) 8/181 (4)
Staphylococcus saprophyticus 8/179 (5) 8/181 (4)
Enterococcus faecalis 3/179 (2) 8/181 (4)
Streptococcus agalactiae 0/179 (0) 2/181 (1)
Klebsiella pneumoniae 3/179 (2) 1/181 (1)
 Other uropathogens 10/179 (6) 9/181 (5)
 Not specified 0/179 (0) 3/181 (2)
Susceptibility to fosfomycin (rate):
 All uropathogens 168/181 (93) 162/177 (92)
E coli 142/143 (99) 142/142 (100)

SD=standard deviation; IQR=interquartile range; UTI=urinary tract infection.

*n=239 in fosfomycin group.

†Range 0-12. Sum of daily symptom sum scores of dysuria, frequency/urgency of micturition, and low abdominal pain, each on a five point scale from 0 (not at all) to 4 (very strong/frequent).

‡Range 0-4

§UTI within past year.

¶Activity impairment assessment, sum score range 0-20.

**n=242 in fosfomycin group.

††Bacterial count >102 cfu/mL.

HHS Vulnerability Disclosure